相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fatty acid amide hydrolase is lower in young cannabis users
Maya R. Jacobson et al.
ADDICTION BIOLOGY (2021)
Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta -analysis
Carmen Schiweck et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
The first evidence of an association between a polymorphism in the endocannabinoid-degrading enzyme FAAH (FAAH rs2295633) with attention deficit hyperactivity disorder
Ali Ahmadalipour et al.
GENOMICS (2020)
FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence
Wei Zhang et al.
ANNALS OF HUMAN GENETICS (2020)
Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders
Jacob Cohen et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Implementation of lipidomics in clinical routine: Can fluoride/citrate blood sampling tubes improve preanalytical stability?
Lisa Hahnefeld et al.
TALANTA (2020)
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete et al.
FRONTIERS IN PSYCHIATRY (2020)
Mutations in sphingolipid metabolism genes are associated with ADHD
Marcela Henriquez-Henriquez et al.
TRANSLATIONAL PSYCHIATRY (2020)
High Glucosylceramides and Low Anandamide Contribute to Sensory Loss and Pain in Parkinson's Disease
Katharina Klatt-Schreiner et al.
MOVEMENT DISORDERS (2020)
Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in mice
Alexandra Vogel et al.
SCIENTIFIC REPORTS (2020)
Criteria and Concurrent Validity of DIVA 2.0: A Semi-Structured Diagnostic Interview for Adult ADHD
Josep Antoni Ramos-Quiroga et al.
JOURNAL OF ATTENTION DISORDERS (2019)
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis
Miquel Bioque et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits
Eric R. Gamazon et al.
NATURE GENETICS (2019)
A Data Science-Based Analysis Points at Distinct Patterns of Lipid Mediator Plasma Concentrations in Patients With Dementia
Robert Gurke et al.
FRONTIERS IN PSYCHIATRY (2019)
CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondria! Fragmentation in Obesity
Philipp Hammerschmidt et al.
CELL (2019)
Attention Deficit/Hyperactivity, the Metabolic Syndrome, and Type 2 Diabetes
Zohar Landau et al.
CURRENT DIABETES REPORTS (2019)
Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder
Nathalie Brunkhorst-Kanaan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits
Sophie E. Legge et al.
JAMA PSYCHIATRY (2019)
Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS/MS method validation and pre-analytical characteristics
R. Gurke et al.
TALANTA (2019)
Ceramides as Novel Disease Biomarkers
Jennifer Kurz et al.
TRENDS IN MOLECULAR MEDICINE (2019)
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach
Suryaprakash Raichur et al.
MOLECULAR METABOLISM (2019)
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis
Nicola Black et al.
LANCET PSYCHIATRY (2019)
Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan
Barbara Franke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety
Andalib Danandeh et al.
PSYCHOPHARMACOLOGY (2018)
Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy
Joern Loetsch et al.
SCIENTIFIC REPORTS (2018)
Wender-Reimherr self-report questionnaire on adult ADHD. German version
P. Retz-Junginger et al.
NERVENARZT (2017)
Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism
Hongmei Wu et al.
LIFE SCIENCES (2017)
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
K. Schmitz et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial
Ruth E. Cooper et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
Judit Lazary et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
FAAH genetic variation enhances fronto-amygdala function in mouse and human
Iva Dincheva et al.
NATURE COMMUNICATIONS (2015)
Low serum sphingolipids in children with attention deficit-hyperactivity disorder
Marcela P. Henriquez-Henriquez et al.
FRONTIERS IN NEUROSCIENCE (2015)
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain
Ermelinda Lomazzo et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance
Sarah M. Turpin et al.
CELL METABOLISM (2014)
ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis
Guilherme V. Polanczyk et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Dietary intervention rescues maternal obesity induced behavior deficits and neuroinflammation in offspring
Silvia S. Kang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Mechanisms underpinning inattention and hyperactivity: neurocognitive support for ADHD dimensionality
G. A. Salum et al.
PSYCHOLOGICAL MEDICINE (2014)
Practitioner Review: What have we learnt about the causes of ADHD?
Anita Thapar et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2013)
Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans
Carmen Walter et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure
M. N. Hill et al.
MOLECULAR PSYCHIATRY (2013)
Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system?
Rebecca M. Craft et al.
LIFE SCIENCES (2013)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee et al.
NATURE GENETICS (2013)
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Ozge Gunduz-Cinar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Ceramide synthases at the centre of sphingolipid metabolism and biology
Thomas D. Mullen et al.
BIOCHEMICAL JOURNAL (2012)
Fatty-acid amide hydrolase polymorphisms and post-traumatic stress disorder after penetrating brain injury
M. Pardini et al.
TRANSLATIONAL PSYCHIATRY (2012)
Elevated Plasma Ceramides in Depression
Patricia Gracia-Garcia et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Biomarkers of Endocannabinoid System Activation in Severe Obesity
Jack C. Sipe et al.
PLOS ONE (2010)
Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review
Thomas A. Sontag et al.
ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS (2010)
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects
P. Monteleone et al.
GENES BRAIN AND BEHAVIOR (2009)
CB1 antagonists for obesity-what lessons have we learned from rimonabant?
Vincenzo Di Marzo et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
ALTERED ANANDAMIDE DEGRADATION IN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
D. Centonze et al.
NEUROLOGY (2009)
Orphan endogenous lipids and orphan GPCRs: A good match
Heather B. Bradshaw et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder
Ake T. Lu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kazuyuki Kitatani et al.
CELLULAR SIGNALLING (2008)
Attention deficit hyperactivity disorder in adults.: Benchmarking diagnosis using the Wender-Reimherr adult rating scale
M. Roesler et al.
NERVENARZT (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
S. E. O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
Marco Bortolato et al.
BIOLOGICAL PSYCHIATRY (2007)
Genetic predictors for acute experimental cold and heat pain sensitivity in humans
H. Kim et al.
JOURNAL OF MEDICAL GENETICS (2006)
Reliability and validity of the German short version of the Wender-Utah Rating Scale for the retrospective assessment of attention deficit/hyperactivity disorder
P Retz-Junginger et al.
NERVENARZT (2003)
Sphingomyelinases:: enzymology and membrane activity
FM Goñi et al.
FEBS LETTERS (2002)
Neuroscience - Endocannabinoid signaling in the brain
RI Wilson et al.
SCIENCE (2002)
分享论文
